Invention Grant
- Patent Title: Combination therapy
-
Application No.: US15428594Application Date: 2017-02-09
-
Publication No.: US10004747B2Publication Date: 2018-06-26
- Inventor: Thomas Klein , Rolf Grempler , Michael Mark
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Marc Began; David L. Kershner
- Priority: EP10162036 20100505; EP11155154 20110221
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/522 ; A61K38/00 ; A61P3/04 ; A61P3/10 ; A61K38/26 ; A61K45/06 ; A61K38/22
Abstract:
The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
Public/Granted literature
- US20170151249A1 COMBINATION THERAPY Public/Granted day:2017-06-01
Information query
